GT Biotech Fund, LP — Form D/A
GT Biotech Fund, LP of Memphis, TN, a pooled investment fund, filed a Form D amendment with the SEC on 2026-07-29. $233.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-07-29
- Form: D/A
- Accession: 0000905148-26-003373
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.1,3C.7
- Amount sold: $233.5M
- Minimum investment: $5K
- Investors: 314
- Security types: fund interests
- SEC file number: 021-362969
Issuer
- Name: GT Biotech Fund, LP
- CIK: 0001806841
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 40 S. Main Street Suite 1900, Memphis, TN, 38103
- Phone: 901-526-9750
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Mary C. Cornpropst | Related Person | Memphis, TN |
| Michael J. Douglass | Related Person | Memphis, TN |
| Ryan E. Gibbs | Related Person | Memphis, TN |
| Darren Kearns | Related Person | Memphis, TN |
| Simone T. Meeks | Related Person | Memphis, TN |
| Justin L. Rikard | Related Person | Memphis, TN |
| Michael J Douglass | Executive Officer | Memphis, TN |
| Justin L Rikard | Executive Officer | Memphis, TN |
| Darren T Kearns | Executive Officer | Memphis, TN |
| n/a Gerber/Taylor Management LLC | Executive Officer | Memphis, TN |
| n/a Gerber/Taylor Management LLC | Promoter | Memphis, TN |
| Simone T Meeks | Executive Officer | Memphis, TN |
| Ryan E Gibbs | Executive Officer | Memphis, TN |
| Mary C Cornpropst | Executive Officer | Memphis, TN |
| Charles C Gerber | Executive Officer | Memphis, TN |
| David G East | Executive Officer | Memphis, TN |
| William E Pickens | Executive Officer | Memphis, TN |
| Justin T Rikard | Executive Officer | Memphis, TN |
| n/a Gerber/Taylor Management Company | Promoter | Memphis, TN |
Other filings by this issuer (8)
More